| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | 0.16 | 0.003 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.097 | 0.003 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.15 | 0.003 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.18 | 0.003 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.17 | 0.003 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | -0.095 | 0.004 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.15 | 0.004 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.14 | 0.004 |